Medirom Healthcare Reports August 2025 KPIs

Ticker: MRM · Form: 6-K · Filed: Sep 24, 2025 · CIK: 1819704

Sentiment: neutral

Topics: kpi, press-release, foreign-private-issuer

TL;DR

Medirom Healthcare dropped its August 2025 KPIs on Sept 24th.

AI Summary

Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for August 2025 in a press release dated September 24, 2025. The filing is a Form 6-K, indicating it's a report from a foreign private issuer.

Why It Matters

This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing them to track the company's performance in the personal services sector.

Risk Assessment

Risk Level: low — This is a routine filing of operational data and does not appear to contain significant new financial or strategic information.

Key Players & Entities

FAQ

What specific Key Performance Indicators (KPIs) were announced by Medirom Healthcare Technologies Inc. for August 2025?

The filing states that Medirom Healthcare Technologies Inc. is issuing a press release announcing its major Key Performance Indicators (KPIs), updated for the month of August 2025, but the specific KPIs are not detailed within this excerpt.

What is the purpose of this Form 6-K filing?

This Form 6-K is being filed by Medirom Healthcare Technologies Inc. to report the issuance of a press release announcing its major Key Performance Indicators (KPIs) for August 2025.

When was the press release announcing the KPIs issued?

The press release announcing the KPIs for August 2025 was issued on September 24, 2025.

Where is Medirom Healthcare Technologies Inc. based?

Medirom Healthcare Technologies Inc. is based in Tokyo, Japan, with its principal executive office located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.

Does Medirom Healthcare Technologies Inc. file annual reports under Form 20-F or 40-F?

Medirom Healthcare Technologies Inc. files its annual reports under cover of Form 20-F.

Filing Stats: 288 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2025-09-24 06:10:10

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: September 24, 2025 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing